Rathbones Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Rathbones Group's MDT Position: Q2 2026 in Review
Rathbones Group reduced its Medtronic (MDT) stake by 30% in Q2 2026, selling an estimated $1.32M and leaving 38,345 shares worth $3M. The position accounts for 0.01% of the portfolio, ranked #269.
Rathbones Group first reported a position in MDT in Q2 2013 and has held it in 23 quarters since. The position peaked at $6.24M in Q3 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Rathbones Group held 38,345 shares of Medtronic worth $3M as of Q2 2026.
- Rathbones Group sold 16,348 Medtronic shares in Q2 2026, an estimated $1.32M.
- Medtronic made up 0.01% of Rathbones Group's portfolio in Q2 2026, its #269 holding.
- Rathbones Group first reported a position in Medtronic in Q2 2013 and has held it in 23 quarters since.
- Rathbones Group's Medtronic position peaked at $6.24M in Q3 2025.
- 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Rathbones Group's 13F filing for Q2 2026, filed 23 Jul 2026.